Ampligen On Trial

Between 1998 and 2004, 234 individuals with severe CFS at 12 clinical sites took part in a study oHemispherxf the experimental therapy rintatolimod, also known as Ampligen. The study met its primary and secondary endpoints for success; however, responders to the drug seem to be buried in the larger group based on the normed results. (PLoS ONE, March 14, 2012)

Tags: , , June 12, 2012